- Home
- HYI vs AMRN Comparison
HYI vs AMRN Comparison
Compare HYI & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HYI
- AMRN
- Stock Information
- Founded
- HYI 2010
- AMRN 1989
- Country
- HYI United States
- AMRN Ireland
- Employees
- HYI N/A
- AMRN N/A
- Industry
- HYI Investment Managers
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- HYI Finance
- AMRN Health Care
- Exchange
- HYI Nasdaq
- AMRN Nasdaq
- Market Cap
- HYI 269.0M
- AMRN 216.0M
- IPO Year
- HYI N/A
- AMRN 1993
- Fundamental
- Price
- HYI $11.85
- AMRN $16.65
- Analyst Decision
- HYI
- AMRN Strong Sell
- Analyst Count
- HYI 0
- AMRN 1
- Target Price
- HYI N/A
- AMRN $7.00
- AVG Volume (30 Days)
- HYI 50.6K
- AMRN 152.6K
- Earning Date
- HYI 01-01-0001
- AMRN 07-30-2025
- Dividend Yield
- HYI 9.59%
- AMRN N/A
- EPS Growth
- HYI N/A
- AMRN N/A
- EPS
- HYI N/A
- AMRN N/A
- Revenue
- HYI N/A
- AMRN $214,112,000.00
- Revenue This Year
- HYI N/A
- AMRN N/A
- Revenue Next Year
- HYI N/A
- AMRN $7.88
- P/E Ratio
- HYI N/A
- AMRN N/A
- Revenue Growth
- HYI N/A
- AMRN N/A
- 52 Week Low
- HYI $10.99
- AMRN $7.08
- 52 Week High
- HYI $12.24
- AMRN $17.18
- Technical
- Relative Strength Index (RSI)
- HYI 51.70
- AMRN 76.68
- Support Level
- HYI $11.82
- AMRN $12.30
- Resistance Level
- HYI $11.94
- AMRN $17.18
- Average True Range (ATR)
- HYI 0.06
- AMRN 1.06
- MACD
- HYI -0.01
- AMRN 0.24
- Stochastic Oscillator
- HYI 35.29
- AMRN 80.65
About HYI Western Asset High Yield Defined Opportunity Fund Inc.
Western Asset High Yield Defined Opps. is a non-diversified, limited-term, closed-end management investment company. The company's investment objective is to provide high income and seek capital appreciation. It invests a majority of its net assets in a portfolio of high-yield corporate fixed-income securities issued or originated by U.S. or foreign public or private corporations and other business entities, with varying maturities.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.